Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Berchuck

Showing results (191-200 of 373) with videos related to

Pageof 38
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 4, 2025
Homologous recombination deficiency and survival in ovarian high-grade serous carcinoma by self-reported raceKatherine A Lawson-Michod, Courtney E Johnson, Mollie E Barnard, et al.
Journal of Women'S Health (2002)|February 18, 2016
The Association Between Body Mass Index and Presenting Symptoms in African American Women with Ovarian CancerChioma O Erondu, Anthony J Alberg, Elisa V Bandera, et al.
Molecular Carcinogenesis|April 12, 2011
Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer riskEllen L Goode, Kristin L White, Robert A Vierkant, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2009
Microarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcomeAndrew Berchuck, Edwin S Iversen, Jingqin Luo, et al.
Gynecologic Oncology|April 17, 2019
Constitutively active ESR1 mutations in gynecologic malignancies and clinical response to estrogen-receptor directed therapiesStéphanie L Gaillard, Kaitlyn J Andreano, Laurie M Gay, et al.
Nature Reviews. Cancer|May 12, 2019
Going to extremes: determinants of extraordinary response and survival in patients with cancerFlurina A M Saner, Alan Herschtal, Brad H Nelson, et al.
Neoplasia (New York, N.Y.)|July 24, 2010
Microcell-mediated chromosome transfer identifies EPB41L3 as a functional suppressor of epithelial ovarian cancersDimitra Dafou, Barbara Grun, John Sinclair, et al.
Frontiers in Oncology|June 21, 2013
Gene expression analysis of early stage endometrial cancers reveals unique transcripts associated with grade and histology but not depth of invasionJohn I Risinger, Jay Allard, Uma Chandran, et al.
Gynecologic Oncology|August 31, 2016
Stress and burnout among gynecologic oncologists: A Society of Gynecologic Oncology Evidence-based Review and RecommendationsIlana Cass, Linda R Duska, Stephanie V Blank, et al.
Nature Communications|May 11, 2026
Ascites protects against ferroptosis and enables the peritoneal growth of ovarian cancerYasaman Setayeshpour, Ssu-Yu Chen, Divya L Dayanidhi, et al.
Pageof 38

Showing results (191-200 of 373) with videos related to

Sort By:
Pageof 38
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 4, 2025
Homologous recombination deficiency and survival in ovarian high-grade serous carcinoma by self-reported raceKatherine A Lawson-Michod, Courtney E Johnson, Mollie E Barnard, et al.
Journal of Women'S Health (2002)|February 18, 2016
The Association Between Body Mass Index and Presenting Symptoms in African American Women with Ovarian CancerChioma O Erondu, Anthony J Alberg, Elisa V Bandera, et al.
Molecular Carcinogenesis|April 12, 2011
Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer riskEllen L Goode, Kristin L White, Robert A Vierkant, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2009
Microarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcomeAndrew Berchuck, Edwin S Iversen, Jingqin Luo, et al.
Gynecologic Oncology|April 17, 2019
Constitutively active ESR1 mutations in gynecologic malignancies and clinical response to estrogen-receptor directed therapiesStéphanie L Gaillard, Kaitlyn J Andreano, Laurie M Gay, et al.
Nature Reviews. Cancer|May 12, 2019
Going to extremes: determinants of extraordinary response and survival in patients with cancerFlurina A M Saner, Alan Herschtal, Brad H Nelson, et al.
Neoplasia (New York, N.Y.)|July 24, 2010
Microcell-mediated chromosome transfer identifies EPB41L3 as a functional suppressor of epithelial ovarian cancersDimitra Dafou, Barbara Grun, John Sinclair, et al.
Frontiers in Oncology|June 21, 2013
Gene expression analysis of early stage endometrial cancers reveals unique transcripts associated with grade and histology but not depth of invasionJohn I Risinger, Jay Allard, Uma Chandran, et al.
Gynecologic Oncology|August 31, 2016
Stress and burnout among gynecologic oncologists: A Society of Gynecologic Oncology Evidence-based Review and RecommendationsIlana Cass, Linda R Duska, Stephanie V Blank, et al.
Nature Communications|May 11, 2026
Ascites protects against ferroptosis and enables the peritoneal growth of ovarian cancerYasaman Setayeshpour, Ssu-Yu Chen, Divya L Dayanidhi, et al.
Pageof 38